Fineline Cube

Follow:
14389 Articles
Trinomab's Retavibart NDA Accepted by NMPA – First Long‑Acting RSV mAb for Infant Protection in China
Others

Trinomab’s Retavibart NDA Accepted by NMPA – First Long‑Acting RSV mAb for Infant Protection in China

CompanyDrug

Sichuan Biokin’s Iza‑Bren Hits PFS and OS Endpoints in Phase III TNBC Study – First Bispecific ADC to Show Dual Survival Benefit

FDA Issues Draft Guidance on Plausible Mechanism Framework – Accelerates Approval Pathway for Individualized Genetic Therapies
Policy / Regulatory

FDA Issues Draft Guidance on Plausible Mechanism Framework – Accelerates Approval Pathway for Individualized Genetic Therapies

Gilead Sciences to Acquire Arcellx for $7.8B – Bolsters CAR‑T Pipeline with BCMA‑Targeted Anito‑cel
CompanyDeals

Gilead Sciences to Acquire Arcellx for $7.8B – Bolsters CAR‑T Pipeline with BCMA‑Targeted Anito‑cel

Company

Pfizer Partners with Sciwind Biosciences for Ecnoglutide China Rights – $495M Deal Marks Metabolic Market Entry

Merck Restructures Human Health into Oncology and Specialty Units – Appoints Oosthuizen and Foard to Lead New Divisions
Company

Merck Restructures Human Health into Oncology and Specialty Units – Appoints Oosthuizen and Foard to Lead New Divisions

Sino Biopharma's Benmelstobart Secures Fourth NMPA Approval for Stage III NSCLC – Expanding PD‑L1 Franchise in China
CompanyDrug

Sino Biopharma’s Benmelstobart Secures Fourth NMPA Approval for Stage III NSCLC – Expanding PD‑L1 Franchise in China

Mabworks’ Obexelimab β Wins NMPA Approval as First Domestic NMOSD Therapy
CompanyDrug

Mabworks’ Obexelimab β Wins NMPA Approval as First Domestic NMOSD Therapy

Findcure Bio Raises $14.5 Million Series B to Advance Radiopharmaceutical Platform
CompanyDeals

Findcure Bio Raises $14.5 Million Series B to Advance Radiopharmaceutical Platform

Siemens Healthineers Deepens Mayo Clinic Partnership on AI Neurology and Precision Oncology
CompanyDeals

Siemens Healthineers Deepens Mayo Clinic Partnership on AI Neurology and Precision Oncology

VivaVision Biotech Files Hong Kong IPO to Advance Ophthalmology Pipeline
CompanyDeals

VivaVision Biotech Files Hong Kong IPO to Advance Ophthalmology Pipeline

Astellas’ VENTANA CLDN18 Assay Wins NMPA Approval as First Companion Diagnostic for VYLOY
Medical Device

Astellas’ VENTANA CLDN18 Assay Wins NMPA Approval as First Companion Diagnostic for VYLOY